TMO vs. UNH: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at TMO and UNH, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | TMO | UNH |
|---|---|---|
| Company Name | Thermo Fisher Scientific Inc. | UnitedHealth Group Incorporated |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Life Sciences Tools & Services | Health Care Providers & Services |
| Market Capitalization | 217.33 billion USD | 295.51 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 17, 1980 | October 17, 1984 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of TMO and UNH by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | TMO | UNH |
|---|---|---|
| 5-Day Price Return | 0.41% | 0.09% |
| 13-Week Price Return | 18.34% | 5.87% |
| 26-Week Price Return | 34.91% | 3.37% |
| 52-Week Price Return | 6.79% | -46.88% |
| Month-to-Date Return | 2.00% | -5.77% |
| Year-to-Date Return | 11.24% | -36.37% |
| 10-Day Avg. Volume | 1.70M | 9.12M |
| 3-Month Avg. Volume | 2.30M | 13.84M |
| 3-Month Volatility | 29.45% | 37.81% |
| Beta | 0.91 | 0.44 |
Profitability
Return on Equity (TTM)
TMO
13.10%
Life Sciences Tools & Services Industry
- Max
- 23.81%
- Q3
- 11.79%
- Median
- 7.51%
- Q1
- 3.14%
- Min
- -6.95%
In the upper quartile for the Life Sciences Tools & Services industry, TMO’s Return on Equity of 13.10% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
UNH
18.60%
Health Care Providers & Services Industry
- Max
- 24.67%
- Q3
- 15.54%
- Median
- 8.37%
- Q1
- 5.49%
- Min
- -2.09%
In the upper quartile for the Health Care Providers & Services industry, UNH’s Return on Equity of 18.60% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
TMO
15.01%
Life Sciences Tools & Services Industry
- Max
- 33.77%
- Q3
- 17.97%
- Median
- 8.97%
- Q1
- 3.80%
- Min
- -11.89%
TMO’s Net Profit Margin of 15.01% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
UNH
4.04%
Health Care Providers & Services Industry
- Max
- 9.33%
- Q3
- 4.80%
- Median
- 2.90%
- Q1
- 0.93%
- Min
- -3.28%
UNH’s Net Profit Margin of 4.04% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
TMO
17.16%
Life Sciences Tools & Services Industry
- Max
- 31.55%
- Q3
- 21.26%
- Median
- 14.06%
- Q1
- 8.54%
- Min
- 0.11%
TMO’s Operating Profit Margin of 17.16% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
UNH
6.03%
Health Care Providers & Services Industry
- Max
- 18.35%
- Q3
- 8.71%
- Median
- 5.10%
- Q1
- 2.10%
- Min
- -3.07%
UNH’s Operating Profit Margin of 6.03% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | TMO | UNH |
|---|---|---|
| Return on Equity (TTM) | 13.10% | 18.60% |
| Return on Assets (TTM) | 6.56% | 5.71% |
| Net Profit Margin (TTM) | 15.01% | 4.04% |
| Operating Profit Margin (TTM) | 17.16% | 6.03% |
| Gross Profit Margin (TTM) | 41.43% | -- |
Financial Strength
Current Ratio (MRQ)
TMO
1.50
Life Sciences Tools & Services Industry
- Max
- 4.76
- Q3
- 2.87
- Median
- 1.75
- Q1
- 1.37
- Min
- 0.57
TMO’s Current Ratio of 1.50 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
UNH
0.95
Health Care Providers & Services Industry
- Max
- 2.00
- Q3
- 1.56
- Median
- 1.28
- Q1
- 0.92
- Min
- 0.01
UNH’s Current Ratio of 0.95 aligns with the median group of the Health Care Providers & Services industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
TMO
0.70
Life Sciences Tools & Services Industry
- Max
- 0.95
- Q3
- 0.70
- Median
- 0.45
- Q1
- 0.18
- Min
- 0.00
TMO’s Debt-to-Equity Ratio of 0.70 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
UNH
0.84
Health Care Providers & Services Industry
- Max
- 2.41
- Q3
- 1.39
- Median
- 0.74
- Q1
- 0.46
- Min
- 0.00
UNH’s Debt-to-Equity Ratio of 0.84 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
TMO
25.18
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
TMO’s Interest Coverage Ratio of 25.18 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
UNH
6.14
Health Care Providers & Services Industry
- Max
- 14.47
- Q3
- 7.46
- Median
- 4.52
- Q1
- 2.04
- Min
- -4.44
UNH’s Interest Coverage Ratio of 6.14 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | TMO | UNH |
|---|---|---|
| Current Ratio (MRQ) | 1.50 | 0.95 |
| Quick Ratio (MRQ) | 1.11 | 0.75 |
| Debt-to-Equity Ratio (MRQ) | 0.70 | 0.84 |
| Interest Coverage Ratio (TTM) | 25.18 | 6.14 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
TMO
0.29%
Life Sciences Tools & Services Industry
- Max
- 1.02%
- Q3
- 0.67%
- Median
- 0.32%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Yield of 0.29% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
UNH
2.67%
Health Care Providers & Services Industry
- Max
- 5.51%
- Q3
- 2.66%
- Median
- 1.06%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 2.67%, UNH offers a more attractive income stream than most of its peers in the Health Care Providers & Services industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio (TTM)
TMO
9.49%
Life Sciences Tools & Services Industry
- Max
- 97.67%
- Q3
- 61.34%
- Median
- 18.53%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Payout Ratio of 9.49% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
UNH
44.61%
Health Care Providers & Services Industry
- Max
- 187.56%
- Q3
- 81.14%
- Median
- 33.42%
- Q1
- 0.00%
- Min
- 0.00%
UNH’s Dividend Payout Ratio of 44.61% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | TMO | UNH |
|---|---|---|
| Dividend Yield (TTM) | 0.29% | 2.67% |
| Dividend Payout Ratio (TTM) | 9.49% | 44.61% |
Valuation
Price-to-Earnings Ratio (TTM)
TMO
33.00
Life Sciences Tools & Services Industry
- Max
- 78.22
- Q3
- 57.42
- Median
- 34.18
- Q1
- 28.39
- Min
- 1.55
TMO’s P/E Ratio of 33.00 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
UNH
16.74
Health Care Providers & Services Industry
- Max
- 48.86
- Q3
- 32.22
- Median
- 21.78
- Q1
- 13.97
- Min
- 8.01
UNH’s P/E Ratio of 16.74 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
TMO
4.95
Life Sciences Tools & Services Industry
- Max
- 10.69
- Q3
- 6.37
- Median
- 4.95
- Q1
- 3.27
- Min
- 1.04
TMO’s P/S Ratio of 4.95 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
UNH
0.68
Health Care Providers & Services Industry
- Max
- 3.66
- Q3
- 1.64
- Median
- 0.72
- Q1
- 0.27
- Min
- 0.10
UNH’s P/S Ratio of 0.68 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
TMO
3.42
Life Sciences Tools & Services Industry
- Max
- 8.12
- Q3
- 5.04
- Median
- 3.94
- Q1
- 2.12
- Min
- 1.13
TMO’s P/B Ratio of 3.42 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
UNH
3.26
Health Care Providers & Services Industry
- Max
- 7.33
- Q3
- 4.33
- Median
- 2.48
- Q1
- 1.31
- Min
- 0.65
UNH’s P/B Ratio of 3.26 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | TMO | UNH |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 33.00 | 16.74 |
| Price-to-Sales Ratio (TTM) | 4.95 | 0.68 |
| Price-to-Book Ratio (MRQ) | 3.42 | 3.26 |
| Price-to-Free Cash Flow Ratio (TTM) | 35.46 | 16.94 |